Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.


TSX:CPH - Post by User

Bullboard Posts
Comment by pabalooon Aug 23, 2020 11:22pm
113 Views
Post# 31444358

RE:RE:RE:RE:I miss all the pharma,biotech,healthcare news

RE:RE:RE:RE:I miss all the pharma,biotech,healthcare newsDefinitely born with a bunch of zeros starting with a one. He simply did the dirty work that needed to be done here nothing else. He fired the past money squanders that blew the company into bankruptcy and is now sitting on a bunch of cash and still has some legacy deals that can bring more revenues and promise to the company. I'm giving him the benefit of the doubt because I was lucky enough to find this company on its  broken legs and I'm hoping for a healer to get us standing. Hoping he makes daddy proud and showers us with cash not sewage. Time will tell but at this point there is no rush as we continue to enjoy a nice royalty business with absolutely little risk. Hoping to see Sun start to promote Absorica LD and increase market share also hoping for a Trulance settlement which must be getting close and lastly hoping for buy backs to begin to get rid of 200 shares dropping the price ten percent 2 minutes from a weekend close. Good luck
Bullboard Posts